1. Home
  2. OFAL vs BIAF Comparison

OFAL vs BIAF Comparison

Compare OFAL & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OFA Group Ordinary Shares

OFAL

OFA Group Ordinary Shares

HOLD

Current Price

$0.10

Market Cap

5.0M

ML Signal

HOLD

Logo bioAffinity Technologies Inc.

BIAF

bioAffinity Technologies Inc.

HOLD

Current Price

$0.67

Market Cap

4.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OFAL
BIAF
Founded
2013
2014
Country
United States
United States
Employees
10
57
Industry
Military/Government/Technical
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
4.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OFAL
BIAF
Price
$0.10
$0.67
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
553.5K
295.8K
Earning Date
06-03-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$20.95
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$0.23
52 Week High
$1.78
$13.50

Technical Indicators

Market Signals
Indicator
OFAL
BIAF
Relative Strength Index (RSI) 22.69 25.46
Support Level N/A $0.61
Resistance Level $0.27 $0.87
Average True Range (ATR) 0.02 0.05
MACD 0.00 0.03
Stochastic Oscillator 8.03 27.49

Price Performance

Historical Comparison
OFAL
BIAF

About OFAL OFA Group Ordinary Shares

OFA Group, through its subsidiary, provides architectural services, including design and fit-out services for commercial and residential buildings in Hong Kong. The design service includes both the consultation with staff and the actual design work and the company provides a specific conceptualized design with layout plans, detailed design drawings, advice relating to, among other things, budgetary consideration, optimal use of space, the materials, fittings, furniture, appliances and other items to be used to produce a preliminary design plan and quotation. Its works include installing protective materials to cover floors or walls, installing or constructing partition walls, windows, window frames, and decorative fittings, furniture or fixtures, installing plumbing systems, etc.

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flow cytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.

Share on Social Networks: